Listar por tema "URINARY-TRACT SYMPTOMS"
Mostrando ítems 1-4 de 4
-
Botulinum neurotoxin A for benign prostatic hyperplasia
(2010)Purpose of review The injection of botulinum neurotoxin A (BoNT-A) into the prostate represents an alternative, minimal invasive treatment for lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH), ... -
The effectiveness of a scientific symposium to change urologists' attitude towards treatment of LUTS/BPH
(2007)Purpose The use of interactive voting systems in continuing education helps to evaluate the alteration in the audience's views after a presentation. This study was designed to evaluate whether urologists' attitude towards ... -
Investigational therapies targeted to the treatment of benign prostatic hyperplasia
(2013)Introduction: The desired goals of treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) include sustained, clinically significant improvement in symptoms and quality of life and/or ... -
Lack of association between the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene polymorphism and the risk of benign prostatic hyperplasia in Caucasian men
(2013)Glucuronidation, mediated by the UDP-glucuronosyltransferase 1A1 (UGT1A1) enzyme, is an important metabolic process during which steroids are converted to more easily excreted compounds in steroid target tissues, such as ...